Loading...
 
Toggle Health Problems and D

More Vitamin D to cells should prevent Uterine Fibroids – Nov 2020

All cells of the body need Vitamin D

For about 30% of the people the Vitamin D Receptor limits the D in the blood from getting to the cells


Vitamin D and uterine leiomyomata: is it time to let the sunshine in?

 Download the PDF from VitaminDWiki

Which is an editorial for the following study


Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation

Fertil Steril. 2020 Oct 7;S0015-0282(20)30710-X. doi: 10.1016/j.fertnstert.2020.07.049
Ana Corachán 1, María Gabriela Trejo 1, María Cristina Carbajo-García 2, Javier Monleón 3, Julia Escrig 3, Amparo Faus 1, Antonio Pellicer 4, Irene Cervelló 1, Hortensia Ferrero 5

Objective: To study whether vitamin D (VitD) inhibits cell proliferation and Wnt/β-catenin and transforming growth factor-β (TGFβ) signaling pathways in uterine leiomyomas independent of mediator complex subunit 12 (MED12) mutation status.

Design: Prospective study comparing leiomyoma vs. myometrial tissues and human uterine leiomyoma primary (HULP) cells treated with or without VitD and analyzed by MED12 mutation status.

Setting: Hospital and university laboratories.

Patient(s): Women with uterine leiomyoma without any treatment (n = 37).

Intervention(s): Uterine leiomyoma and myometrium samples were collected from women undergoing surgery because of symptomatic leiomyoma pathology.

Main outcome measure(s): Analysis of Wnt/β-catenin and TGFβ pathways and proliferation by quantitative real-time polymerase chain reaction in leiomyoma and myometrial tissue as well as in VitD-treated HULP cells analyzed by Sanger sequencing.

Results: Sequencing data showed that 46% of leiomyomas presented MED12 mutation, whereas no mutations were detected in adjacent myometrium. Expression of Wnt/β-catenin and TGFβ pathway genes was significantly increased in MED12-mutated leiomyomas compared to matched myometrium; no significant differences were found in wild-type (WT) leiomyomas. In HULP cells, VitD significantly decreased PCNA expression of both MED12-mutated and WT groups. VitD treatment decreased WNT4 and β-catenin expression in both groups compared to controls, with significance for WNT4 expression in MED12-mutated samples. Similarly, VitD significantly inhibited TGFβ3 expression in cells from both groups. MMP9 expression also decreased.

Conclusion: Despite molecular differences between MED12-mutated and WT leiomyomas, VitD inhibited Wnt/β-catenin and TGFβ pathways in HULP cells, suggesting VitD as an effective treatment to reduce proliferation and extracellular matrix formation in different molecular subtypes of uterine leiomyomas.


Created by admin. Last Modification: Saturday December 5, 2020 14:46:46 GMT-0000 by admin. (Version 2)

Attached files

ID Name Comment Uploaded Size Downloads
14675 Uterine Fibroids editorial.pdf PDF 2020 admin 05 Dec, 2020 14:45 70.81 Kb 93
See any problem with this page? Report it (FINALLY WORKS)